A single route to evaluate new diagnostic tests for COVID-19
CONDOR is accelerating how quickly promising COVID-19 diagnostics make it into real-world use. The platform is evaluating new COVID-19 diagnostics in the settings they will be used, such as in GP surgeries, care homes or hospitals, as well as their performance in laboratory settings.
These tests will be used to support diagnosis and management of patients with suspected COVID-19, and collect data to help develop effective diagnostic pathways for subsequent waves of infection in the post-pandemic setting.
The platform comprises a number of partners, including Manchester University’s Diagnostic and Technology Accelerator (DiTA), and NIHR MedTech and In Vitro Diagnostics Co-operatives (MICs) based in Oxford, Leeds, London and Newcastle.
Industry and Diagnostic developers
Click here for how to submit your diagnostic / kit for inclusion in CONDOR.